JUVA — Juva Life Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Juva Life, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.967 | 3.87 | 5.76 |
Cost of Revenue | |||||
Gross Profit | — | 0 | 0.428 | 1.25 | 0.482 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.17 | 6.94 | 12.7 | 14.2 | 16.7 |
Operating Profit | -2.17 | -6.94 | -11.7 | -10.3 | -10.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.37 | -8.98 | -16.2 | -11.3 | -10.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.37 | -8.98 | -16.2 | -11.4 | -10.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.37 | -8.98 | -16.2 | -11.4 | -10.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.37 | -8.98 | -16.2 | -11.4 | -10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | -0.071 | -0.125 | -0.074 | -0.067 |